Refractory schizophrenia and atypical antipsychotics

@article{Taylor2000RefractorySA,
  title={Refractory schizophrenia and atypical antipsychotics},
  author={David Taylor and D. Duncan-McConnell},
  journal={Journal of Psychopharmacology},
  year={2000},
  volume={14},
  pages={409 - 418}
}
Treatment resistant or refractory schizophrenia is a difficult to define condition of largely unknown prevalence. For 10 years, clozapine has been the standard treatment in this condition and is recognized unequivocally as being effective. However, clozapine is sometimes poorly tolerated and has the potential for severe toxicity. Partly as a result of this, other atypicals have recently been evaluated as treatments for refractory schizophrenia. In order to evaluate the evidence base relating to… Expand
Drugs in development for the treatment of schizophrenia
  • R. Emsley
  • Medicine
  • Expert opinion on investigational drugs
  • 2009
Atypical antipsychotics: revolutionary or incremental advance?
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 63 REFERENCES
Treatment-resistant schizophrenia--the role of clozapine.
  • H. Meltzer
  • Medicine
  • Current medical research and opinion
  • 1997
An open trial of clozapine in neuroleptic-resistant childhood-onset schizophrenia.
Newer atypical antipsychotic medication versus clozapine for schizophrenia.
...
1
2
3
4
5
...